Get breaking ophthalmic news, device and drug updates, clinical trial coverage, thought-leader perspective, and industry announcements.
Key Takeaways Moorfields Private has introduced specialist eye assessments for patients taking GLP-1 medications, including ...
Key Takeaways Two AAO case reports examine cryopreserved amniotic membrane in neurotrophic keratitis and severe HSV keratitis ...
Get breaking ophthalmic news, device and drug updates, clinical trial coverage, thought-leader perspective, and industry ...
Both Zenkuda and tabirafusp-ted met the phase 3 DAYBREAK primary endpoints, achieving noninferiority to aflibercept for vision gains at 1 year in patients with wet AMD Kodiak reported that 54% of ...
MyEyeDr. has agreed to acquire EyeCare Partners' optometry division, including more than 300 offices across 5 eye care brands MyEyeDr. said the expanded organization will support greater access to ...
B+L Advances Two Ophthalmic Pipeline Therapies in DED and Ocular Surface Pain ...
Claris Biotherapeutics will relocate its headquarters from Jersey City, New Jersey, to South San Francisco, California, effective October 2026 The company plans to begin pivotal studies of CSB-001 ...
Merck's Remigromig Meets Primary Endpoint in Phase 2b/3 BRUNELLO Trial for DME ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results